As for human therapy utilizing immunomodulatory effects of Tregs, induction of the Treg population with IL-2 has been successful in treating type 1 diabetes, alopecia areata, and hepatitis C virus-induced vasculitis (119). Here, IL2 is linked to type 1 diabetes mellitus.